# Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141

> **NCT02522481** · PHASE3 · COMPLETED · sponsor: **Bracco Diagnostics, Inc** · enrollment: 175 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Lumason

## Key facts

- **NCT ID:** NCT02522481
- **Lead sponsor:** Bracco Diagnostics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-24
- **Primary completion:** 2017-11-07
- **Final completion:** 2018-02-25
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2021-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02522481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02522481, "Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT02522481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*